Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

As expected, use of calcium/vitamin D supplementation was positively associated with past history of fracture, with incidence rate ratios (Poisson regression) between 1.2 and 1.8, all p < 0.001.

Source: Characteristics of the study participants. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Calcium and Vitamin D Supplementation Are Not Associated With Risk of Incident Ischemic Cardiac Events or Death: Findings From the UK Biobank Cohort

Study design awaiting verification · Journal of Bone and Mineral Research · 2018

Original publication title

Calcium and Vitamin D Supplementation Are Not Associated With Risk of Incident Ischemic Cardiac Events or Death: Findings From the UK Biobank Cohort

Nicholas C Harvey; Stefania D'Angelo; Julien Paccou; Elizabeth M Curtis; Mark Edwards; Zahra Raisi‐Estabragh; Karen Walker‐Bone; Steffen E Petersen; Cyrus Cooper

© 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

We investigated associations between calcium/vitamin D supplementation and incident cardiovascular events/deaths in a UK population‐based cohort. UK Biobank is a large prospective cohort comprising 502,637 men and women aged 40 to 69 years at recruitment. Supplementation with calcium/vitamin D was self‐reported, and information on incident hospital admission (ICD‐10) for ischemic heart disease (IHD), myocardial infarction (MI), and subsequent death was obtained from linkage to national registers. Cox proportional hazards models were used to investigate longitudinal relationships between calcium/vitamin D supplementation and hospital admission for men/women, controlling for covariates.

A total of 475,255 participants (median age 58 years, 55.8% women) had complete data on calcium/vitamin D supplementation. Of that number, 33,437 participants reported taking calcium supplements; 19,089 vitamin D; and 10,007 both. In crude and adjusted analyses, there were no associations between use of calcium supplements and risk of incident hospital admission with either IHD, or subsequent death. Thus, for example, in unadjusted models, the hazard ratio (HR) for admission with myocardial infarction was 0.97 (95% confidence interval [CI] 0.79 to 1.20, p = 0.79) among women taking calcium supplementation.

Corresponding HR for men is 1.16 (95% CI 0.92 to 1.46, p = 0.22). After full adjustment, HR (95% CI) were 0.82 (0.62 to 1.07), p = 0.14 among women and 1.12 (0.85 to 1.48), p = 0.41 among men. Adjusted HR (95% CI) for admission with IHD were 1.05 (0.92 to 1.19), p = 0.50 among women and 0.97 (0.82 to 1.15), p = 0.77 among men. Results were similar for vitamin D and combination supplementation. There were no associations with death, and in women, further adjustment for hormone‐replacement therapy use did not alter the associations.

In this very large prospective cohort, there was no evidence that use of calcium/vitamin D supplementation was associated with increased risk of hospital admission or death after ischemic cardiovascular events. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.

Authors’ abstract

ABSTRACT

We investigated associations between calcium/vitamin D supplementation and incident cardiovascular events/deaths in a UK population‐based cohort. UK Biobank is a large prospective cohort comprising 502,637 men and women aged 40 to 69 years at recruitment. Supplementation with calcium/vitamin D was self‐reported, and information on incident hospital admission (ICD‐10) for ischemic heart disease (IHD), myocardial infarction (MI), and subsequent death was obtained from linkage to national registers. Cox proportional hazards models were used to investigate longitudinal relationships between calcium/vitamin D supplementation and hospital admission for men/women, controlling for covariates.

A total of 475,255 participants (median age 58 years, 55.8% women) had complete data on calcium/vitamin D supplementation. Of that number, 33,437 participants reported taking calcium supplements; 19,089 vitamin D; and 10,007 both. In crude and adjusted analyses, there were no associations between use of calcium supplements and risk of incident hospital admission with either IHD, or subsequent death. Thus, for example, in unadjusted models, the hazard ratio (HR) for admission with myocardial infarction was 0.97 (95% confidence interval [CI] 0.79 to 1.20, p = 0.79) among women taking calcium supplementation.

Corresponding HR for men is 1.16 (95% CI 0.92 to 1.46, p = 0.22). After full adjustment, HR (95% CI) were 0.82 (0.62 to 1.07), p = 0.14 among women and 1.12 (0.85 to 1.48), p = 0.41 among men. Adjusted HR (95% CI) for admission with IHD were 1.05 (0.92 to 1.19), p = 0.50 among women and 0.97 (0.82 to 1.15), p = 0.77 among men. Results were similar for vitamin D and combination supplementation. There were no associations with death, and in women, further adjustment for hormone‐replacement therapy use did not alter the associations.

In this very large prospective cohort, there was no evidence that use of calcium/vitamin D supplementation was associated with increased risk of hospital admission or death after ischemic cardiovascular events. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.

Publication and source details

Original title: Calcium and Vitamin D Supplementation Are Not Associated With Risk of Incident Ischemic Cardiac Events or Death: Findings From the UK Biobank Cohort

Nicholas C Harvey; Stefania D'Angelo; Julien Paccou; Elizabeth M Curtis; Mark Edwards; Zahra Raisi‐Estabragh; Karen Walker‐Bone; Steffen E Petersen; Cyrus Cooper

Journal of Bone and Mineral Research · 2018

* Address correspondence to: Cyrus Cooper, MRC, FMedSci, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK. E‐mail: cc@mrc.soton.ac.uk
†

SEP and CC are joint senior authors.

© 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.UK Medical Research Council4050502589British Heart FoundationArthritis Research UKNational Osteoporosis SocietyInternational Osteoporosis FoundationNational Institute for Health Research Southampton Biomedical Research CentreUniversity of Southampton and University Hospital Southampton NHS Foundation TrustNational Institute for Health Research Musculoskeletal Oxford Biomedical Research CentreUniversity of OxfordNational Institute for Health Research Cardiovascular Biomedical Research Unit at BartsWellcome Trust and National Institute for Health Research

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T12:41:52.784556+00:00

DOI: 10.1002/jbmr.3375 · PMC5915292